Quick Answer
DNA X, Inc. reported Revenue (ASC 606) of $50.92 million for fiscal year 2024.
DNA X, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2024 | $50.92M | -45.6% |
| 2023 | $93.63M | +34.1% |
| 2022 | $69.83M | +28.0% |
| 2021 | $54.57M | -14.7% |
| 2020 | $63.99M | -45.0% |
| 2019 | $116.25M | -14.3% |
| 2018 | $135.66M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.21M | +7.9% | +44.9% |
| June 30, 2025 | $11.19M | -2.8% | -33.1% |
| March 31, 2025 | $16.72M | +83.4% | +11.3% |
| September 30, 2024 | $15.02M | -45.5% | +30.4% |
| June 30, 2024 | $11.52M | -57.1% | +26.3% |
| March 31, 2024 | $9.12M | -64.7% | -66.9% |
| September 30, 2023 | $27.57M | +34.5% | +2.7% |
| June 30, 2023 | $26.84M | +124.5% | +4.0% |
- DNA X, Inc. showed a decrease of -45.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2018–2024 period, DNA X, Inc.’s revenue (asc 606) has declined by 62.5% (from $135.66 million to $50.92 million).
- The most recent figure is from DNA X, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: